Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ping An Biomedical Co's Enterprise Value is $16.82 Mil.
Ping An Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil. Therefore, Ping An Biomedical Co's EV-to-EBIT ratio for today is -8.37.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ping An Biomedical Co's Enterprise Value is $16.82 Mil.
Ping An Biomedical Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil. Therefore, Ping An Biomedical Co's EV-to-EBITDA ratio for today is -8.38.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Ping An Biomedical Co (NAS:PASW) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ping An Biomedical Co's EV-to-EBITDA for today is:
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil.
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2025 was $4.75 Mil.
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.90 Mil.
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.90 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ping An Biomedical Co Enterprise Value Related Terms
Ping An Biomedical Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for Ping An Biomedical Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PASW vs DXYN, CULP, UFI: Enterprise Value Comparison
For the Textile Manufacturing subindustry, Ping An Biomedical Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ping An Biomedical Co Enterprise Value vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ping An Biomedical Co's Enterprise Value falls into.
Ping An Biomedical Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ping An Biomedical Co's Enterprise Value for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ping An Biomedical Co (PASW) has a Enterprise Value of $16.82 Mil as of Jul. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ping An Biomedical Co and its competitors.
Is Ping An Biomedical Co's Enterprise Value too high?
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's Enterprise Value compare to DXYN and CULP?
Ping An Biomedical Co's Enterprise Value of $16.82 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Manufacturing - Apparel & Accessories company?
A good Enterprise Value depends on the Manufacturing - Apparel & Accessories industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ping An Biomedical Co and its competitors. Ping An Biomedical Co's current Enterprise Value is $16.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current Enterprise Value of $16.82 Mil. The current Enterprise Value is $16.82 Mil. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current Enterprise Value is $16.82 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score
Get the complete analysis for PASW
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PASW has been successfully added to your 
